- The trend backdrop is active with a 41-week active streak.
- Price is above the Trend Line, keeping the weekly tape constructive.
- Price is above Fair Value, showing premium demand versus the model.
- Activity pressure is positive on the latest completed week.
QZG
SES
Week ended 21 Aug 2026
Weekly Investor Report
Accrelist Ltd. · Healthcare · Medical Care Facilities
Latest close
0.09 SGD
47.5%
latest week
Weekly setup
Constructive, but selective
The weekly trend is active. Price is 63.7% above the Trend Line and sits at 88.1% of its 52-week range. The latest completed week returned 47.5%, after a 45.2% four-week move. The latest news-sentiment score is 50/100.
Setup score
71
out of 100
Latest Close
0.09 SGD
21 Aug 2026
1W Return
47.5%
latest completed week
4W Return
45.2%
short-term follow-through
12W Return
63.6%
quarterly tape
Trend Breadth
78.8%
41 of 52 weeks active
Volume Ratio
6.9x
vs 13-week average
- Next-week expectancy is negative at 37.05% based on similar historical setup states.
- 5 reversal markers appear in the recent smart-money tape.
- Recent volatility is running well above the one-year baseline.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
47.5%
Latest completed week; four-week move 45.2%.
Indicator stack
88/65
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Negative 37.05%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
News sentiment
50/100
2 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is active. Price is 63.7% above the Trend Line and sits at 88.1% of its 52-week range. The latest completed week returned 47.5%, after a 45.2% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 6.9x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
14 Aug
21 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.7812-week average 0.75
12-week confirmation
Trend active12/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure12/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership12/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.78Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers55 reversal markers
No recent accumulation markers. 5 reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 45.2% over four weeks, 63.6% over 12 weeks, and 157.1% over one year. The current trend has remained active for 41 consecutive weeks.
Performance by holding period
Active trend streak41 weeks
Active weeks in one year41
Trend breadth78.8%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure0.97Latest activity-pressure read.
Pressure change-26.3%Four-week change in activity pressure.
Leadership59.37Latest relative-leadership reading.
RS change294.8%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment50/100
Weighted news tone is neutral across 2 relevant articles.
0 positive · 2 neutral · 0 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-8.2%Distance below the 52-week high.
13-week volatility12.9%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
27 Feb
27 Mar
24 Apr
22 May
19 Jun
17 Jul
21 Aug
Weeks higher12 of 267 weeks finished lower.
Best week+47.5%Week of 21 Aug.
Worst week-11.5%Week of 3 Apr.
Latest week+47.5%Week of 21 Aug.
Shape of recent returns
Strong gains6
Modest gains6
Flat weeks7
Modest losses5
Sharp losses2
Recent vol12.9%13-week weekly-return volatility.
Base vol9.4%52-week weekly-return volatility.
Up/down split22/17Count of positive and negative weeks in the 52-week window.
Average skew9.3% / -5.3%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorSG Healthcare
4-week rank1 / 35
Group average-3.1%
Trend breadth25.7%
Trend25.7%active weekly trend signals
MD31.4%positive activity pressure
RS20.0%positive relative leadership
Four-week leaders
IndustrySG Medical Care Facilities
4-week rank1 / 17
Group average2.7%
Trend breadth29.4%
Trend29.4%active weekly trend signals
MD23.5%positive activity pressure
RS29.4%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape67/100
Trend, activity pressure, participation, and risk combine to a 67/100 tape read.
Indicator analysis79/100Latest 12-week confirmation: trend 12/12, activity pressure 12/12, relative leadership 12/12.
Activity pressure 0.78; 5 reversal markers Next-Week ExpectancyNegative 37.05%Next-week expectancy is negative with a 37.05% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment50/100Weighted news tone is neutral across 2 relevant articles.
Accrelist Ltd. Revenue Breakdown – SGX:QZG Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 21 Aug 2026 | 0.09 SGD | 47.5% | 0.055 SGD | 0.044 SGD | 0.97 | 59.37 | 25.5M | On |
| 14 Aug 2026 | 0.061 SGD | 1.7% | 0.0536 SGD | 0.0437 SGD | 0.72 | 8.59 | 12.0M | On |
| 7 Aug 2026 | 0.06 SGD | 0.0% | 0.0531 SGD | 0.0437 SGD | 0.77 | 8.15 | 445.0K | On |
| 31 Jul 2026 | 0.06 SGD | -3.2% | 0.0529 SGD | 0.0436 SGD | 1.11 | 9.99 | 364.8K | On |
| 24 Jul 2026 | 0.062 SGD | 0.0% | 0.0523 SGD | 0.0436 SGD | 1.32 | 15.04 | 254.9K | On |
| 17 Jul 2026 | 0.062 SGD | -1.6% | 0.0518 SGD | 0.0436 SGD | 1.39 | 17.41 | 2.5M | On |
| 10 Jul 2026 | 0.063 SGD | -3.1% | 0.0513 SGD | 0.0435 SGD | 1.37 | 21.00 | 4.9M | On |
| 3 Jul 2026 | 0.065 SGD | 6.6% | 0.0508 SGD | 0.0435 SGD | 1.12 | 31.11 | 210.8K | On |
| 26 Jun 2026 | 0.061 SGD | 0.0% | 0.0502 SGD | 0.0434 SGD | 0.87 | 25.61 | 610.2K | On |
| 19 Jun 2026 | 0.061 SGD | 10.9% | 0.0496 SGD | 0.0434 SGD | 0.69 | 26.55 | 172.1K | On |
| 12 Jun 2026 | 0.055 SGD | 1.9% | 0.0489 SGD | 0.0433 SGD | 0.52 | 18.75 | 201.0K | On |
| 5 Jun 2026 | 0.054 SGD | -1.8% | 0.0485 SGD | 0.0433 SGD | 0.36 | 16.58 | 200.0K | On |
| 29 May 2026 | 0.055 SGD | 3.8% | 0.0479 SGD | 0.0433 SGD | 0.06 | 19.54 | 726.2K | On |
| 22 May 2026 | 0.053 SGD | 3.9% | 0.0472 SGD | 0.0434 SGD | -0.19 | 14.97 | 10.0M | On |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.